-
EDITORIAL
From the human genome sequencing onwards
R. Cingolani
-
COVER STORY
PIRAMAL – Five critical mistakes to avoid in API development and manufacturing
-
LATEST NEWS
Pharma’s fear for Amazon: they attack without warning and take no prisoners when taking over the market
A. Santoro
-
COLUMN: INTELLECTUAL PROPERTY
IP consulting and documentation: the importance of specialists
G. Tagliafico, S. Venturini
-
COLUMN: COMPLIANCE
The globalisation of compliance risks. Compliance programmes in cross-border markets
A. R. Carnà
-
COMPANY PROFILE
Olon acquires manufacturing facility in India
-
Column: REGULATION
International stage set to decide on rules for emerging biological technologies
L. Van Der Meer
-
COMPANY PROFILE
Dorra Pharma – Proven performance and passion for pharma at global level
-
SUPPLY CHAIN
Current trends and challenges in pharmaceutical product distribution
M. Egger
-
SUPPLY CHAIN
Patient-centric packaging starts with formulation development
E. Elias
-
SUPPLY CHAIN
The efficient planning of temperature-controlled storage for pharmaceutical products
A. Sponheimer
-
COMPANY PROFILE
Callery lays the foundation for secure supply
-
SUPPLY CHAIN
Patient centricity in the pharmaceutical supply chain
C. Buonamico
-
MARKET ACCESS
Routes to commercialisation
A. Casse
-
MARKETPLACE
Adoptive T-cell therapies – The next generation of cancer therapies
B. Gilmore
-
MARKETPLACE
What to expect in Pharmaceuticals and Life Sciences sectors? Results from the 21st PwC CEO Survey
A. Fortuna
-
MARKETPLACE
Patient adherence; addressing the largest global therapeutic area with packaging solutions
C. Waterhouse
-
MARKETPLACE
Mid-year review: the top 10 deals of 2018
P. Van Arnum
-
COLUMN: MERGERS AND ACQUISITIONS
Midyear analysis: partnering transactions show no signs of slowing down in 2018
P. Winter, K. Pihl-Carey
-
MERGERS AND ACQUISITIONS
Life sciences M&As in the second quarter of 2018: notes, trends and a closer look at APAC
E. Cruces
Click here to read the e-version of VOL. 2(3), 2018
Recent Posts
- TOGETHER FOR SUSTAINABILITY ANNOUNCES NEW UPDATES TO THE PCF GUIDELINE
- Pharmapack Predictions 2025: the Good the Bad and…. the Donald 2.0
- Countdown to Barcelona: Registrations open for Vitafoods Europe 2025
- Shimadzu Corporation to Mark 150th Anniversary with Special Celebrations
- CPHI Milan – Pharma prepares for CDMO growth in 2025 as CPHI Milan reports record attendance
